financetom
Business
financetom
/
Business
/
Equinor Drops Plans to Build Hydrogen Pipeline From Norway to Germany
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Equinor Drops Plans to Build Hydrogen Pipeline From Norway to Germany
Sep 21, 2024 7:37 PM

02:28 PM EDT, 09/20/2024 (MT Newswires) -- Equinor ( EQNR ) said Friday it will no longer pursue plans to export hydrogen from Norway to Germany because the pipeline project is not deemed viable.

The Norwegian energy company in 2023 signed a memorandum of understanding with German energy supplier RWE to jointly develop large-scale energy value chains. The deal included building facilities in Norway to produce low-carbon hydrogen from natural gas that will be brought to Germany via a pipeline.

"Without a financial framework for the hydrogen pipeline, we have made the decision to terminate the technical maturation of the Clean Hydrogen to Europe project, which includes the low-carbon hydrogen production facility planned in Norway and the export pipeline to Germany," Equinor ( EQNR ) spokesperson Magnus Frantzen Eidsvold told MT Newswires.

Equinor ( EQNR ), however, continues to develop other hydrogen initiatives and projects in its hydrogen portfolio, which is still early phase.

"In addition to regulatory framework, the main challenge is to get the necessary customer base and that there is solid long-term demand for hydrogen to underpin projects," Eidsvold said.

RWE could not be reached for comment.

Price: 24.82, Change: -0.04, Percent Change: -0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CompoSecure Completes Spin-Off of Resolute Holdings Into Separate Public Company
CompoSecure Completes Spin-Off of Resolute Holdings Into Separate Public Company
Feb 28, 2025
07:32 AM EST, 02/28/2025 (MT Newswires) -- CompoSecure ( CMPO ) said Friday it completed the spin-off of its subsidiary, Resolute Holdings Management (RHLD), into an independent public company. As part of the separation, the company said its shareholders received one share of Resolute Holdings for every 12 shares of CompoSecure ( CMPO ) common stock held as of February...
Perrigo Issues Medium-Term Financial Outlook
Perrigo Issues Medium-Term Financial Outlook
Feb 28, 2025
07:42 AM EST, 02/28/2025 (MT Newswires) -- Perrigo ( PRGO ) said Friday it expects fiscal 2025 adjusted earnings of $2.90 to $3.10 per diluted share. Analysts surveyed by FactSet expect $3.01 per share. The comapny pegs full-year organic net sales growth at 2.5% to 4.5%. Perrigo ( PRGO ) said it projects adjusted EPS compound annual growth rate of...
Docebo Q4 Results Beat Estimates, but Q1 Revenue Outlook Is Lower Than Expected
Docebo Q4 Results Beat Estimates, but Q1 Revenue Outlook Is Lower Than Expected
Feb 28, 2025
07:36 AM EST, 02/28/2025 (MT Newswires) -- Docebo ( DCBO ) , a learning platform provider, on Friday reported a beat in adjusted profit and revenue for the fourth quarter, while also providing a lower-than-expected revenue outlook for the first quarter of 2025. The company reported adjusted net income of US$8.7 million for the three months ended Dec. 31, compared...
Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma
Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma
Feb 28, 2025
07:40 AM EST, 02/28/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a conditional marketing authorization for linvoseltamab to treat adults with relapsed and refractory multiple myeloma. The company said the recommendation specifically covers patients who have received at least three prior...
Copyright 2023-2026 - www.financetom.com All Rights Reserved